Current Opinion in Cardiology

Article	Citations
Racial and ethnic disparities in heart failure: current state and future directions	85
Impact of social determinants of health on cardiovascular disease prevention	61
Artificial intelligence and machine learning in aortic disease	30
Genetics of hypertriglyceridemia and atherosclerosis	29
COVID-19 myocarditis and long-term heart failure sequelae	26
Genetics of dilated cardiomyopathy	23
Triglycerides and cardiovascular disease	23
Artificial intelligence in pediatric cardiology: taking baby steps in the big world of data	19
Risk factors of sudden cardiac death in hypertrophic cardiomyopathy	19
Racial disparities in Coronavirus Disease 2019 (COVID-19) outcomes	18
Endocan: a new marker of endothelial function	17
Interactions of hypertension, obesity, left ventricular hypertrophy, and heart failure	16
RNA therapeutics for cardiovascular disease	15
Genetics of atrial fibrillation	15
Management of hypertension in heart failure with preserved ejection fraction: is there a blood pressure goal?	14
Epidemiology and risk factors for stroke in young individuals: implications for prevention	14
Statin intolerance: new data and further options for treatment	14
Racial differences in outcomes after receiving advanced heart failure therapies	13
Mobile health in preventive cardiology: current status and future perspective	13
Contemporary perspectives on the genetics and clinical use of lipoprotein(a) in preventive cardiology	12
The cardiac surgeon's guide to artificial intelligence	12
The landscape of cardiogenic shock: epidemiology and current definitions	11
Emergent expansion of clinical epigenetics in patients with cardiovascular diseases	11
Pulsed field ablation: a promise that came true	10
Every child with congenital heart disease should be exercising	10

Mitral valve surgery for rheumatic heart disease: replace, repair, retrain?	10
Cybersecurity threats to cardiac implantable devices: room for improvement	10
Coronavirus disease 2019: a comprehensive review and meta-analysis on cardiovascular biomarkers	10
Long noncoding RNAs in cardiovascular disease	10
Atypical atrial flutter: review of mechanisms, advances in mapping and ablation outcomes	10
Permission to prescribe: do cardiologists need permission to prescribe diabetes medications that afford cardiovascular benefit?	10
Challenges in diagnosis and management of coarctation of the aorta	10
A tale of two balloons: technical and procedural difference between cryoballoon systems	10
The impact of socioeconomic status and race on the outcomes of congenital heart disease	9
Cardiac rehabilitation for coronary artery disease: latest updates	9
Machine learning: at the heart of failure diagnosis	9
Disparities in acute decompensated heart failure	9
Pulmonary hypertension in heart failure	9
Coronary plaque features on CTA can identify patients at increased risk of cardiovascular events	9
Temporary mechanical circulatory support devices: updates from recent studies	8
Clinical approach to genetic testing in amyloid cardiomyopathy: from mechanism to effective therapies	8
Evaluation of coronary stenosis versus plaque burden for atherosclerotic cardiovascular disease risk assessment and management	8
Sleep apnea and cardiovascular risk	8
Coronary artery disease in patients with cancer: challenges and opportunities for improvement	8
Regionalization of congenital cardiac surgical care: what it will take	8
Myocardial infarction with nonobstructive coronary artery disease (MINOCA): a review of pathophysiology and management	8
N-3 polyunsaturated fatty acids for cardiovascular risk	8
Arrhythmogenic right ventricular cardiomyopathy in the pediatric population	8
Medical management of resistant hypertension: the role of sodium-glucose cotransporter 2 inhibitors (SGLT2i)	8
Cardiovascular disease prevention in individuals with underlying chronic inflammatory disease	8
Global interventions in hypertension: new and emerging concepts	8
The pleiotropic cardiovascular effects of sodium-glucose cotransporter-2 inhibitors	8
Transcatheter mitral valve replacement: an update	8
Multimodality cardiac imaging and new display options to broaden our understanding of the tricuspid valve	8
Epigenetic remodeling in heart failure with preserved ejection fraction	8
Hypertensive crisis: diagnosis, presentation, and treatment	7
The emerging role of cardiac contractility modulation in heart failure treatment	7
Cardiovascular implications and complications of the coronavirus disease-2019 pandemic: a world upside down	7
The role of temporary mechanical circulatory support as a bridge to advanced heart failure therapies or recovery	7
The shock team: a multidisciplinary approach to early patient phenotyping and appropriate care escalation in cardiogenic shock	7
Peripheral arterial disease and hypertension	7
Surgical options for aortic root aneurysm disease: which procedure, which patient	6
Antiplatelet therapy in percutaneous coronary intervention: latest evidence from randomized controlled trials	6
New findings bearing on the prevention, detection and management of high blood pressure	6
The genetics of left ventricular noncompaction	6
Advances in contemporary medical management to treat patients with heart failure	6
Optimal medical therapy after coronary artery bypass grafting: a primer for surgeons	6
Supporting the Ross procedure: preserving root physiology while mitigating autograft dilatation	6
Coronary artery bypass grafting in low ejection fraction: state of the art	6
Mobile health technologies in the diagnosis and management of atrial fibrillation	6
Percutaneous left atrial appendage occlusion	6
Skeletal muscle (dys)function in heart failure with preserved ejection fraction	6
Are the current evaluation tools for advanced therapies biased?	6
The current landscape of lipoprotein(a) in calcific aortic valvular disease	6
Cardiovascular consequences of vaping	6

Coronary microvascular dysfunction and heart failure with preserved ejection fraction: what are the mechanistic links?	5
Transcatheter treatment of severe tricuspid regurgitation	5
Semaglutide for weight loss and cardiometabolic risk reduction in overweight/obesity	5
New aspects in the management of hypertension in the digital era	5
Preoperative optimization and rapid discharge after coronary artery bypass grafting	5
Update on cardiovascular risk in nonalcoholic fatty liver disease	5
Personalized external aortic root support in aneurysm disease	5
Bicuspid aortic valve associated aortopathy: 2022 guideline update	5
Adverse pregnancy outcomes and future risk of heart failure	5
Artificial sweeteners and cardiovascular risk	5
Electronic health strategies to improve medication adherence in patients with cardiometabolic disease: current status and future directions	5
Review of transapical off-pump mitral valve intervention with NeoChord implantation	5
Gender differences in acute aortic syndromes	5
Patient-specific preprocedural planning for tricuspid valve repair and replacement procedures	5
Representation of Black patients in heart failure clinical trials	5
How to deal with nonsevere stenoses in coronary artery bypass grafting – a critical perspective on competitive flow and surgical precision	5
Vascular regenerative cells in cardiometabolic disease	5
Clinical trials of cell therapy for heart failure: recent results warrant continued research	4
Is the world ready for the STICH 3.0 trial?	4
Primary prevention statin therapy in older adults	4
Peripartum cardiomyopathy: risk factors and predictors of outcome	4
Impact of ultrasound enhancing agents on clinical management	4
Cardiac amyloidosis: an update on diagnosis, current therapy, and future directions	4
Storage solutions to improve grafts preservation and longevity in coronary artery bypass grafting surgery: hype or hope?	4
Diet and vascular risk	4
Chronic thromboembolic pulmonary hypertension anno 2021	4
Resurgence of the edge-to-edge repair of the mitral valve	4
The role of multimodality imaging in patients with heart failure with reduced and preserved ejection fraction	4
Genetics of sudden cardiac death	4
Current evidence on the safety and efficacy of combined atrial fibrillation ablation and left atrial appendage closure	4
Hypertension and cognitive function: a review of life-course factors and disparities	4
Coronary artery calcium testing in young adults	4
The influence of age and sex on the prognostic importance of traditional cardiovascular risk factors, selected circulating biomarkers and other markers of subclinical cardiovascular damage	4
Factor XI inhibitors: what should clinicians know	3
Engaging medical students in cardiac surgery: a focus on equity, diversity, and inclusion	3
The role of skeletal muscle mass on cardiovascular disease risk: an emerging role on modulating lipid profile	3
Management of pregnancy in left ventricular assist device and heart transplant recipients: a concise review	3
Destination LVAD therapy in the current era of the heart transplant allocation system	3
Genetics of atrial fibrillation	3
Review new concepts in pharmacotherapy for peripheral arterial disease	3
Update on the molecular landscape of thoracic aortic aneurysmal disease	3
The role of icosapent ethyl in cardiovascular risk reduction	3
The use of multidisciplinary teams, electronic health records tools, and technology to optimize heart failure population health	3
Economics and laboratory efficiency of atrial fibrillation ablation	3
Are serum uric acid levels predictors of cardiovascular risk? An update	3
Current and future transcatheter aortic valve replacement valves	3
Eliminating hypertension disparities in U.S. non-Hispanic black adults: current and emerging interventions	3
The functional medicine approach to atrial fibrillation: can a cure for atrial fibrillation be found in the gut?	3
Assessment of the tricuspid valve using cardiovascular magnetic resonance	3
Antiplatelet therapy around CABG: the latest evidence	3
Beyond Weight Loss: the Emerging Role of Incretin-Based Treatments in Cardiometabolic HFpEF	3
Surgical repair of ischemic mitral regurgitation: one ring does not fit all	3
Hybrid and endovascular approaches to the aortic arch	2
The potential of CRISPR-Cas9 prime editing for cardiovascular disease research and therapy	2
RNA interference-based therapies for the control of atherosclerosis risk factors	2
Novel devices for managing heart failure	2
Influenza vaccination in mitigating vascular events and risk	2
Antithrombotic therapy after transcatheter aortic valve replacement: current perspective	2
Glucagon-like peptide-1/glucose-dependent insulinotropic polypeptide receptor co-agonists for cardioprotection, type 2 diabetes and obesity: a review of mechanisms and clinical data	2
The systemic right ventricle in adult congenital heart disease: why is it still such a challenge and is there any hope on the horizon?	2
Pulmonary arterial hypertension in pregnancy	2
New concepts in heart failure with preserved ejection fraction and hypertension	2
Understanding the next circulation: lymphatics and what the future holds	2
Catheter-based therapies in acute and chronic pulmonary embolism	2
Low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol and apolipoprotein B for cardiovascular care	2
The anatomy of enjoyment: the flow experience and cardiac surgery	2
Implementation of remote monitoring strategies to improve chronic heart failure management	2
Cardiac rehabilitation for heart failure: progress and gaps in evidence and policy	2
Structural genomic variants in thoracic aortic disease	2
Coronavirus disease 2019, hypertension, and renin–angiotensin–aldosterone system inhibitors	2
Coronavirus disease 2019 and the cardiologist	2
Surgical treatment of severe tricuspid regurgitation	2
When is enough, enough? Exploring ethical and team considerations in paediatric cardiac care dilemmas	2
Cardiovascular utility of single cell RNA-Seq	2
Transcatheter tricuspid valve intervention: to repair or to replace?	2
Update on cancer therapy-induced atherosclerosis	2
Impact of PCSK9 inhibitors on coronary atheroma phenotype following myocardial infarction: insights from intravascular imaging	2
Coronary artery calcium and sudden cardiac death: current evidence and future directions	2
Percutaneous management of calcified coronary arteries – review of atherectomy and lithotripsy devices and why it is important	2
What cardiologists should know about cardiac sarcoidosis in 2022?	2

Cardiac magnetic resonance findings in cardiac amyloidosis	2
Editorial: The year in hyperlipidaemia	2
Brugada syndrome – minimizing overdiagnosis and over treatment in children	2
Pharmacogenetics of cardiovascular drugs	2
Unanswered questions on coronary artery graft patency and clinical outcomes	2
Weight loss and atrial fibrillation: a review	2
Salt restriction for treatment of hypertension – current state and future directions	2
Distinct pathological mechanisms distinguish acute coronary syndrome caused by plaque erosion from plaque rupture	2
Measuring lipoprotein(a) for cardiovascular disease prevention – in whom and when?	2
Genetics of aortic valve disease	2
Selection of percutaneous mechanical circulatory support in cardiogenic shock: patient-specific considerations and insights from contemporary clinical data	2
Combined transcatheter mitral and tricuspid edge-to-edge repair: expanding the horizons of interventional heart failure	2
Evaluation and management of drug-eluting stent in-stent restenosis	2
Polygenic risk scores in coronary artery disease	2
Myocardial infarction with nonobstructive coronary arteries: the need for precision medicine	2
Management of the Fontan patient during pregnancy	2
Less invasive multivessel coronary artery bypass grafting: now is the time	2
Chronic heart failure management in adult patients with congenital heart disease	2
Obesity/cardiometabolic phenotype of heart failure with preserved ejection fraction: mechanisms to recent trials	2
Ambulatory advanced heart failure patients: timing of mechanical circulatory support – delaying the inevitable?	2
Inclisiran and cardiovascular events: a comprehensive review of efficacy, safety, and future perspectives	2
Heart transplant donation after circulatory death: current status and implications	2
Building new cardiac vasculature and myocardium: where are we at?	2